Gastroenterology CME

Carcinoid Syndrome: Updates in Pathophysiology, Diagnosis, and Treatment consists of a single lecture and discussion by Drs. Matthew H. Kulke and C. Metz.

After viewing Carcinoid Syndrome, you will be better able to:
• Summarize the cause of carcinoid syndrome
• Perform an appropriate workup and differential diagnosis from presenting symptoms
• Adopt evidence-based best practices in managing carcinoid syndrome, including strategies to address refractory or poorly controlled symptoms
• Evaluate safety and efficacy of current and emerging treatment approaches for carcinoid syndrome

Target Audiences:
This program is intended for US-based medical oncologists, endocrinologists and gastroenterologists, as well as oncology physician assistants, nurse practitioners, and nurses involved in the diagnosis and management of carcinoid tumors and carcinoid syndrome.

Inflammatory bowel disease (IBD) is a broad term that includes many different forms of inflammatory bowel conditions, the most common of which are Crohn’s Disease and ulcerative colitis, the former of which affects any area of the alimentary canal.

After reviewing Crohn’s Disease: Therapeutic Updates, Barriers to Care, and Emerging Therapies, you will be better able to:
• Describe the strengths and weaknesses of present and emerging diagnostic techniques, where applicable in Crohn’s disease.
• Describe strengths of different professional organizations’ guidance in Crohn’s disease diagnosis and treatment guidelines
• Describe emerging therapies in the treatment of Crohn’s disease.
• Describe barriers to care in the treatment of Crohn’s disease and suggest ways to ameliorate them.
• Identify the present treatment options currently available for management of Crohn’s disease and apply them to patient cases using evidence-based medicine.

Target Audience:
Healthcare professionals specializing in: gastroenterology, internal medicine, or those who otherwise commonly care for patients with Crohn’s disease.

This course contains two courses:
• Crohn’s Disease: Therapeutic Updates, Barriers to Care, and Emerging Therapies (1 hr CME)
• Inflammatory Bowel Disease (IBD): A Global Approach to Quality Management and Barriers to Care in an Era of Resource Consciousness(1.25 hr CME)

In order to get credit from ScientiaCME, you must first establish a username and password.

Target Audience:
Healthcare professionals specializing in colon and rectal surgery, family medicine, internal medicine, gastroenterology, oncology, pain management, palliative care, primary care, proctology, and other clinicians who treat patients suffering from gastrointestinal disorders.

Chronic Idiopathic Constipation (CIC) discusses conventional therapies: bulking agents, softeners, stimulants, osmotics; recent additions and investigational agents: prucalopride, plecanatide, linaclotide, lubiprostone; non-pharmacologic therapies and their place relative to pharmacotherapy: dietary, mechanical, behavioral, and surgical interventions; biofeedback; and clinical pearls and difficult-to-treat cases.

After reviewing Chronic Idiopathic Constipation (CIC), you will be able to:
• Describe the pathophysiology of chronic idiopathic constipation
• Describe the benefits and risks of pharmacotherapy for chronic idiopathic constipation and take them into account when formulating a treatment plan for different patients
• Formulate an evidence-based treatment plan for a variety of patients with chronic idiopathic constipation.
• Recommend therapy changes in patients with chronic idiopathic constipation who do not respond to a previously prescribed treatment

Target Audience:
Gastroenterologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in gastroenterology; and any other healthcare professionals with an interest in or who clinically encounter patients with chronic idiopathic constipation.

This site offers numerous brief presentations concerning Hepatitis B (HBV), Hepatitis C (HBC), Hepatic Encephalopathy (HE) and Hepatocellular Carcinoma (HCC).

Target Audiences:
Hepatology, Gastroenterology and any medical professional who serves patients with chronic liver disease.

About 17 text-based or case-based-interactive activities concerned with aspects of Hepatitis B and Hepatitis C infection.

All of these categories offer CME credit: Conference Coverage, Journal Options, Management Series, Treatment Updates, Annual Updates and Interactive Cases.

Recent presentations include:
• Highlights From Amsterdam 2013: HCV Phase III Studies and Approved Agents
• Management of Chronic Hepatitis B Virus Infection in Women of Reproductive Age
• Hepatitis Highlights
• So You Think You’re a Hepatitis C Expert, Educational Material, Part 3
• Updates in Viral Hepatitis from AASLD 2012
• Treat or Wait in HCV? A Series of Challenging Case Vignettes

Target Audience: Physicians focusing on Infectious Disease and related specialties.

The goal of the Gi Health Foundation is to provide health professionals with the most current education and information on gastrointestinal health.

Major areas of focus are: Irritable Bowel Syndrome; Inflammatory Bowel Disease; Crohn’s Disease; Ulcerative Colitis; and Fecal Incontinence.

Some recent topics include:
• The Great Debates in Functional GI Disorders: Discussing the Clinical Implications of Fecal Incontinence and IBS
• Xpert Perspectives from UEGW… Reporting on IBS
• Xpert Perspectives from ACG… Reporting on IBS
• Management of Irritable Bowel Syndrome With Constipation (IBS-C): From Conventional to New and Emerging Pharmacologic Therapies

Target Audience: Physicians specializing in Gastroenterology, Internal Medicine, and Family Medicine

A set of brief (30 minutes) case simulations about:
• Hepatitis A (3)
• Hepatitis B (14)
• Hepatitis C (6)
• Common Management Issues (2) and
• Health Educator (2).

Target Audience: Physicians focusing on Family Medicine, Internal Medicine, and Infectious Disease

Only the webcasts offer CME credit. Of these, 13 are in Oncology; other areas are Hematology (7) and Gastroenterology (6). Many of the webcasts offer multiple modules.

Target Audiences:
Physicians specializing in Hematology, Oncology, or Gastroenterology.

CME activities of special interest to gastroenterologists.

Medscape contains a variety of educational formats:

CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.

CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.

SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)

CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

Target Audience: Gastroenterologists